I
Inhibrx Biosciences, Inc. (INBX)
NMS – Real Time Price. Currency in USD
94.81
-0.50 (-0.52%)
At close: Jun 26, 2026, 4:00 PM EDT
94.81
-0.00 (-0.00%)
After-hours: Jun 26, 2026, 4:31 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
94.81
-0.50 (-0.52%)
At close: Jun 26, 2026, 4:00 PM EDT
94.81
-0.00 (-0.00%)
After-hours: Jun 26, 2026, 4:31 PM EDT
No Data
There are no news for this stock.
Total debt $180.9M significantly exceeds cash reserves ($161.7M), raising financial stability concerns
Total current assets $171.3M exceed Total current liabilities $26.5M, highlighting excellent liquidity
Debt-to-equity ratio (-8.6) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-8.8x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$38.0M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 6.46 | 6.05 | 10 | |
| Quick ratio | 6.46 | 5.63 | 10 | |
| Debt to Equity | N/A | 0.30 | 1.0 | |
| Debt to Assets | 0.98 | 1.04 | 2.0 | |
| Interest coverage | -8.81 | -16.91 | 1.0 | |
| Weighted average score | 4.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 2M | 2M | 200K | 1M | 1M |
| Gross Profit | N/A | 609K | -2M | -1M | -1M |
| Operating Income | -129M | -219M | -331M | -135M | -123M |
| Net Income | -145M | -241M | 1.69B | -140M | -130M |
| EBITDA | -128M | -218M | -329M | -133M | -121M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -100 | -23.24 | 1.0 |
| Next quarter | N/A | -6.58 | 1.0 |
| Current year | -100 | -2.16 | 1.0 |
| Next year | N/A | 29.29 | 5.5 |
| Weighted average score | 2.1 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -1.84 | -1.89 | -26.23 | 3.3 |
| Y/Y | 999 | 22.79 | 23.21 | -5.86 | 7.8 |
| 3y average | 147.75 | 208.24 | N/A | -12.01 | 5.5 |
| 5y average | N/A | N/A | N/A | N/A | 1.0 |
| Weighted average score | 4.4 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |